EP2858640
Composition for use in a method of treating overweight and obesity in patients with high cardiovascular risk
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.6.2013EP published:
25.3.2020EP application number:
13800883.4
EPO information:
European Patent Register
Max expiry date:
4.6.2033
Title:
Composition for use in a method of treating overweight and obesity in patients with high cardiovascular risk
Timeline
Today
5.6.2013EP application
25.3.2020EP Publication
Owner
Name:
Nalpropion Pharmaceuticals LLCAddress:
10 North Place Park, Suite 201, Morristown, NJ 07960, US
Inventor
Name:
KLASSEN, PrestonAddress:
La Jolla, CA 92037, US
Name:
TAYLOR, KristinAddress:
San Diego, CA 92127, US
Priority
Number:
201261656451 PDate:
6.6.2012Country:
US
Classification
Categories:
A61K 31/137, A61K 31/485, A61K 9/20, G01G 19/414, G09B 5/06, G09B 19/00, A61P 3/04, A61P 9/00, A61P 9/04, A61P 9/10